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Abstract
The simulated dataset of the Genetic Analysis Workshop 14 provided affection status and the
presence or absence of 12 traits. It was determined that all affected individuals must have traits E,
F and H (EFH phenotype) and they must also have either trait B (B subtype) or traits C, D, and G
(CDG subtype). A genome screen was performed, and linkage peaks were identified on
chromosomes 1, 3, 5, and 9 using microsatellite markers. Dense panels of single-nucleotide
polymorphism (SNP) markers were ordered for each of the four linkage peaks. In each case,
association analyses identified a single SNP that accounted for the linkage evidence. The SNP on
chromosome 1 appeared to primarily influence the B subtype, while the SNPs on chromosomes 5
and 9 primarily influenced the CDG subtype. The chromosome 3 SNP had the strongest effect and
influenced both subtypes, as well as the requisite EFH phenotype. Recognizing the two subtypes
prior to linkage analysis was key to identifying these loci using only a single replicate. This highlights
the need in real life situations for careful examination of the phenotypic data prior to genetic
analysis.
Background
Studies designed to identify genes contributing to com-
plex diseases have been ongoing for many years, utilizing
different study designs and methods with varied success.
The simulated dataset of the Genetic Analysis Workshop
14 (GAW14) provided an opportunity to evaluate the
standard analysis techniques used to identify genes under-
lying complex phenotypes. We have also attempted to
predict disease status given the presence of apparent "high
risk" or deleterious alleles (those alleles associated with
disease) identified in our analyses.
Methods
All analyses were performed using the simulated dataset
without knowledge of the underlying model, including
number of genes or their location. Analyses were per-
formed with complete genotypic and phenotypic data
from replicate 1. The true model was obtained only at
GAW14, and was used in this report to verify our findings.
No additional results or figures were generated after learn-
ing the simulation model.
Phenotype in populations
As the effect of genes may differ across subpopulations,
each was analyzed separately as well as together. The link-
age methods employed did not allow for large pedigrees;
therefore, only the isolated populations – Aipotu (AI),
Karangar (KA), and Danacaa (DA) – were used for linkage
analysis. The large families recruited from the heterogene-
ous urban setting (NYC) were only used in secondary
association analyses. The simulated dataset included a
number of discrete traits as well as the affection status for
the simulated disease. Presence or absence of specific
traits was tabulated for each population among affecteds
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and unaffecteds. Disease subtypes based on these traits
were assigned to each individual for future analyses.
Genetic analysis
A genome screen was performed for affection status, as
well as for each of the disease subtypes, using the nonpar-
ametric linkage analysis methods implemented in ALLE-
GRO [1]. To assist in prioritizing regions for further study,
panels of dense single-nucleotide polymorphisms (SNPs)
were purchased for those chromosomal locations with
LOD scores greater than 2.0.
Association analyses were performed for each of the SNPs
contained in these panels, using the transmission disequi-
librium test and discordant sib-pair test implemented in
the pedigree disequilibrium test (PDT) [2]. Tests were
conducted for each of the subtypes identified above.
Evaluation of penetrance
A single individual was randomly chosen from each fam-
ily, and for each SNP the percentage of individuals with
the corresponding phenotype was tabulated for those car-
rying 0, 1, and 2 deleterious alleles. This process was
repeated 10,000 times and the bootstrapped mean pene-
trance is reported.
Prediction of phenotype
Logistic regression was used to quantify the effects of the
apparent deleterious alleles identified in these genetic
analyses. Affection status and the subtypes were each used
in turn as the dependent variable. The number of copies
for each of the deleterious alleles was used as an inde-
pendent variable. Interactions between genes and with sex
were also added. Those variables without a significant




Upon close inspection of affected individuals, it was dis-
covered that all affected individuals had traits E, F, and H
(the EFH phenotype). It was discovered that two subtypes
existed. In addition to the EFH phenotype, affected indi-
viduals had to have either trait B (the B subtype) or they
had to have traits C, D, and G (the CDG subtype). This
rule held true for all populations; however, different pop-
ulations had different ratios of the two subtypes. All
affected individuals in the DA population had the B sub-
type, and all of the affected individuals in the KA popula-
tion had the CDG subtype (see Table 1). Affected
individuals in the AI and NYC populations had a mixture
Table 1: Summary of subtypes within each population in replicate 1.
% Affected
Population Total B subtype CDG subtype EFH phenotype
Aipotu (AI) 41.1 65.1 62.6 100.0
Danacaa (DA) 36.9 100.0 10.9 100.0
Karangar (KA) 34.9 41.3 100.0 100.0
New York (NY) 29.1 71.5 59.9 100.0
All populations 34.9 69.9 57.8 100.0
Table 2: Genome screen results (LOD scores) for replicate 1
Trait, all populations (position in cM) Affection status (position in cM)
Chr. B subtype CDG subtype EFH phenotype Aipotu (AI) Danacaa (DA) Karangar (KA) All populations
1 12.3 (162)a 1.1 5.6 (166) 1.6 5.4 (162) 0.7 5.5 (158)
2 0.7 0.6 0.9 0.7 1.5 0.6 1
3 3.5 (290) 2.6 (290) 4.4 (290) 3.7 (288) 2.2 (290) 3.5 (290) 9.3 (290)
4 1 0.8 1.2 1.3 1 1.5 1.2
51 . 24.8 (7) 3.7 (7) 0.9 1.2 4.8 (1) 3.6 (1)
6 1.1 1.6 1 1 1 1.1 1.1
7 1.6 1 0.8 1.1 1.4 0.7 0.9
8 0.6 1.1 0.5 0.4 1 0.6 0.5
91 . 7 4 (8) 2.5 (9) 0.7 1.9 4.5 (2) 2.5 (5)
10 1 1.5 0.6 0.6 0.5 1.2 0.6
aAll suggestive (> 2.2) and significant (≥ 3.6) LOD scores are bold.BMC Genetics 2005, 6:S142
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of the two subtypes. There was considerable overlap
between the two subtypes in all populations.
Genetic analyses
Linkage analyses identified four chromosomal regions
with LOD scores greater than 2.0. Only one region, chro-
mosome 3, was consistently seen in all subtypes and in all
populations. Linkage to the region on chromosome 1 was
only seen when analyzing the B subtype or the DA popu-
lation. Conversely, the regions on chromosomes 5 and 9
were only seen in the CDG subtype and in the KA popula-
tion (see Table 2).
Data for additional markers in these regions were
obtained for follow-up studies. Packets 27, 28, and 29
were ordered for chromosome 1, packet 153 for chromo-
some 3, packet 207 from chromosome 5, and packet 417
for chromosome 9. Association studies were performed
on all additional markers using the program PDT. A SNP
on chromosome 3 (B03T3056) yielded the most signifi-
cant result (p-value = 2.3 × 10-20) (see Table 3). Several
SNPs near B03T3056 were also significantly associated
with affection status, suggesting that this SNP was part of
a "high-risk" haplotype. However, all of the information
from the haplotypes was captured in B03T3056, suggest-
ing that the ancestral haplotype had not fully decayed.
Slight linkage disequilibrium (LD) was observed in this
chromosomal region (D' = 0.68; r2 = 0.16).
The deleterious allele could not be identified in the 3
packets directly under the chromosome 1 linkage peak
when only affection status was examined. However, when
the B subtype was used (recall that the strongest linkage to
chromosome 1 was with the B subtype), B01T0561 was
identified (p-value = 0.001). Similarly, the deleterious
SNPs on chromosome 5 (B05T4136; p-value = 0.01) and
chromosome 9 (B09T8333; p-value = 5.0 × 10-7) were
identified using the CDG phenotype.
Evaluation of penetrance
Chromosome 3 (B03T3056) had the strongest contribu-
tion to disease risk, and its effect appeared additive (Figure
1). Chromosome 1 (B01T0561) had similar penetrances
for those with 1 and 2 alleles and was later modeled as a
dominant susceptibility gene. Chromosomes 5
(B05T4136) and 9 (B09T8333) had similar penetrances
for those with 0 or 1 copy of the deleterious allele and
were modeled as recessive susceptibility genes.
Prediction of phenotype
Using these four identified SNPs, logistic regression was
able to classify individuals as either affected or unaffected
with 65.3% accuracy. When logistic regression was instead
used to predict the subtypes and the predicted subtypes
used to infer affection status, accuracy of disease classifica-
tion remained the same. When the SNPs on chromo-
somes 1, 5, and 9 were modeled as additive (i.e., three
levels: 0, 1, or 2 alleles) instead of dominant/recessive
(i.e., two levels), several odds ratios decreased, but the
predictive accuracy did not change. Interactions between
genes or with sex were always non-significant. Similar lev-
els of significance – 63.4% and 63.5% – were noted for
replicates 2 and 3, when using the same beta values from
the model obtained with replicate 1.
Estimated penetrance of identified SNPs for their corre- sponding phenotype Figure 1
Estimated penetrance of identified SNPs for their corre-
sponding phenotype.
Table 3: Association results for the 4 deleterious SNPs identified in replicate 1
Average PDT chi-square value (p-value)
Chr Packet SNP disease allele affection status B subtype CDG subtype EFH phenotype
1 029 B01T0561 2 1.5 (0.22) 10.5 (10-3) 0.5 (0.47) 0.3 (0.61)
3 153 B03T3056 1 85.5 (2.3 × 10-20) 55.2 (10-12)4 4 . 3  ( 3  ×  1 0 -11) 85.6 (2 × 10-20)
5 207 B05T4136 1 2.4 (0.12) 1.5 (0.22) 6.4 (0.01) 1.6 (0.21)
9 417 B09T8333 2 14.8 (10-4) 1.1 (0.30) 25.3 (5 × 10-7) 14.7 (10-4)
aThe most significant p-value for each chromosome is bolded.BMC Genetics 2005, 6:S142
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Discussion
Analysis of the individual traits identified two subtypes of
the simulated disease. All affected individuals had the
EFH phenotype (i.e., all three discrete traits E, F, and H),
but they could be classified into the B subtype (presence
of trait B) or the CDG subtype (presence of all three traits
C, D, and G). Three genome screens were performed, sub-
stituting the presence of these three phenotypes for affec-
tion status. Evidence of linkage differed depending on
which subtypes were included as affected in the analysis.
This observation matched closely to the true underlying
disease model, unknown at the time, in which there were
three ways an individual could become affected. The B
subtype corresponds to the P1 phenotype. The CDG sub-
type corresponds to the P2 phenotype. And the third type
detailed in the model (P3) required traits B, C, D, and G;
however, since a subset of these traits were sufficient to
cause disease, this was not recognized, and was not neces-
sary to identify the underlying genes.
We identified what we thought was the underlying disease
polymorphism for each of the linkage regions on chromo-
somes 1, 3, 5, and 9. The SNP on chromosome 3
(B03T3056) had by far the strongest effect and exhibited
an additive effect for all forms of the disease (i.e., having
two copies was worse than one copy, which was worse
than no copies of the deleterious allele). The SNP on chro-
mosome 1 (B01T0561) appeared to act in an autosomal
dominant manner, because there was no additional
increase in risk if an individual had two copies of the del-
eterious allele versus just one. This SNP also appeared to
affect only the B subtype and did not influence the CDG
subtype. The SNPs on chromosomes 5 (B05T4136) and 9
(B09T8333) both appeared to follow an autosomal reces-
sive mode of inheritance and both affected only the CDG
subtype and not the B subtype. The disease model is sum-
marized in the schematic of Figure 2.
The accuracy of classifying individuals as affected or unaf-
fected based on these genotypes did not exceed 65.3%.
This was originally interpreted as consistent with the exist-
ence of additional genes, environment and/or phenotypic
variation not accounted for in the model. In fact, the
major reason why the accuracy of disease classification
was not greater was because the causative SNPs used in the
simulation parameters to determine affection status were
not provided in the fine mapping dataset. However, the
"high-risk" haplotypes were identified, as well as the SNP
that tagged these haplotypes most efficiently. Two addi-
tional modifier genes on different chromosomes were not
identified (D5 and D6) due to their weak effect on the
diagnostic phenotype.
Only five GAW14 studies correctly identified the major
loci and haplotypes without having the "answers" or with-
out grouping together all 100 replicates. Part of the reason
for this is that a good understanding of the phenotype,
namely identifying the two subtypes, was critical to reach-
ing significance in any one replicate. Only two other
groups correctly detailed these subtypes and all three dis-
covered them in a different way. Our group tabulated the
frequencies of the traits between affected and unaffected
individuals, and performed genetic analyses after stratify-
ing by subtype. Alternatively, MacGregor et al. incorpo-
rated qualitative covariates into their linkage analysis [3],
while Liu et al. used machine learning to derive the pat-
terns in the phenotype data [4].
Conclusion
The ability to increase power to detect linkage based on
minor phenotypic differences in a heterogeneous disease
is a particularly important lesson to apply to real-world
studies. A few groups were successful in identifying all
four major disease loci because the ratio of subtypes was
skewed in certain populations and because they analyzed
these populations separately. However, this was only a
proxy for the underlying subtypes and the same genes are
not usually as influential among different isolated and
admixed populations. The most important lesson from
these results, obtained from simulated data, is that
because phenotypic heterogeneity is often due to geno-
typic heterogeneity, as was the case here, it is vital that all
available phenotypic information be analyzed thoroughly
before genetic analyses are begun if the goal is to identify
as many causal genes as possible.
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